Clinical Trials Logo

Taurine in Cancer Colon clinical trials

View clinical trials related to Taurine in Cancer Colon.

Filter by:
  • None
  • Page 1

NCT ID: NCT04192539 Completed - Clinical trials for Taurine in Cancer Colon

The Prospect of Using Serum Taurine Level as a Potential Biomarker for Early Detection of Colorectal Carcinoma and Its Correlation With Other Prognostic Markers

Start date: January 18, 2017
Phase: N/A
Study type: Interventional

Serum taurine results in this study showed that, besides CRC biomarkers; it is most attractive, more precious and more accurate early biomarker for early detecting of any malignant change which may led to CRC by other mean it is the most sensitive and more specific tumor marker for CRC. As a result, we can recommend measuring its level regularly with other prognostic tumor biomarkers and screening examination for all people with abdominal and gastrointestinal problems and for precancerous patients as a pre-early biomarker for colorectal carcinoma. So, it needs further studies to confirm that observations on large scale of population as it obvious the small sample size in early stage and lack data due to limited financial resources and it needs more efforts to collect first and precancerous stages patients.